Other names: ADT
Categories: Prescription Medication
Description:
Androgen Deprivation Therapy (ADT) is a critical component of treatment for locally advanced prostate cancer (T3–T4) and is almost always used in combination with external beam radiation therapy (EBRT). ADT lowers testosterone levels, which prostate cancer cells depend on for growth and survival.
For locally advanced disease, long-term ADT—typically 18 to 36 months—is recommended, based on strong evidence showing improved overall survival and reduced recurrence when used with radiation. Common agents include leuprolide, goserelin, degarelix, and relugolix. While effective, prolonged ADT can cause side effects such as hot flashes, loss of libido, fatigue, bone thinning, and metabolic changes, so patients should be monitored and counseled on managing these risks.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the effectiveness of 'Androgen Deprivation Therapy' against 'Prostate Cancer, Locally Advanced Disease'. The author of the content has not provided a review or rating for this treatment, making it difficult to assess its efficacy without further data.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
